Sign up for a free trial now
  • Login
  • Subscribe
  • Take a FREE Trial
  • About Us
  • Contact us
  • RSS

19 June 2013


The Pharma Letter
  • Home
  • 7 Day Premium Trial
  • Pharmaceuticals
  • Biotechnology
  • Generics
  • Events
  • Companies
  • Drugs
  • Subscribe

Brinzolamide Ophthalmic Suspension Articles

CHMP removes uncertainty over Tyverb, recommending approval; views other drugs

5 May 2008

Alcon's income down 22% to $232M in 3rd-qtr

30 October 2006

Alcon granted European approval for Azopt

17 April 2000

Alcon granted European approval for Azopt

14 April 2000

Showing 1-4 of 4 articles

Go to beginningPrevious
  • 1
NextGo to end
  • Hot Topics
  • Most Read
  • FDA probes two deaths possibly linked to Lilly's antipsychotic Zyprexa Relprevv
  • Negative US patent ruling for Novo Nordisk on Prandin
  • Aspen Pharma offers to buy GlaxoSmithKline's thrombosis brands and manufacturing site
  • US Supreme Court says patent settlement can "sometimes" be illegal
  • Daiichi Sankyo files for Japanese approval of Prasugrel
  • FDA probes two deaths possibly linked to Lilly's antipsychotic Zyprexa Relprevv
  • Negative US patent ruling for Novo Nordisk on Prandin
  • Aspen Pharma offers to buy GlaxoSmithKline's thrombosis brands and manufacturing site
  • US Supreme Court says patent settlement can "sometimes" be illegal
  • Daiichi Sankyo files for Japanese approval of Prasugrel

30 Day Premium Trial


Events

Twitter Right banner

RSS



© 2013 thepharmaletter.com

  • Home
  • RSS
  • About Us
  • Subscribe
  • Terms and Conditions
  • Article Archive
Site powered by WORKSsitebuilder CMS